Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Allergol Int ; 58(4): 573-83, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19776675

RESUMO

BACKGROUND: B7-H2 is a ligand for the inducible costimulator (ICOS). The aim of this study was to examine the expression and function of B7-H2 in human airway smooth muscle (ASM) cells and compare them with those of CD40 or OX40 ligand (OX40L). METHODS: Expression of B7-H2, CD40 and OX40L in ASM cells and their respective counterparts in T cells was analyzed by RT-PCR or flow cytometry. The modulating effect of polyinosinic-polycytidylic acid (poly I:C) on expression of B7-H2, CD40 and OX40L was also examined. The function of these three molecules was evaluated by virtue of adhesion of anti-CD3-activated T cells, IL-6 and IL-8 production and DNA synthesis. RESULTS: ASM cells constitutively expressed B7-H2, CD40 and OX40L that mediated adhesion of activated T cells expressing ICOS, CD40L and OX40. ASM cells responded to poly I:C with upregulated expression of B7-H2, CD40 and OX40L and displayed enhanced adhesion of activated T cells. Functional analysis performed on untreated ASM cells showed that engagement of B7-H2 with ICOS-Ig clearly induced DNA synthesis, whereas that of CD40 or OX40L with trimeric CD40L or OX40-Ig greatly increased IL-6 and IL-8 production. These responses were enhanced in poly I:C-treated ASM cells. CONCLUSIONS: The data demonstrate that ASM cells express functionally active B7-H2, CD40 and OX40L and suggest that B7-H2-dependent signaling may play an active role in a proliferative response rather than in cytokine and chemokine production. In addition, the modulation of B7-H2, CD40 and OX40L expression and function by poly I:C may have important implications for the function of virus-infected ASM cells.


Assuntos
Antígenos CD/biossíntese , Miócitos de Músculo Liso/metabolismo , Linfócitos T/metabolismo , Antígenos CD/genética , Antígenos de Diferenciação de Linfócitos T/biossíntese , Antígenos de Diferenciação de Linfócitos T/genética , Complexo CD3/imunologia , Antígenos CD40/biossíntese , Antígenos CD40/genética , Adesão Celular/imunologia , Separação Celular , Células Cultivadas , Citometria de Fluxo , Humanos , Ligante Coestimulador de Linfócitos T Induzíveis , Proteína Coestimuladora de Linfócitos T Induzíveis , Interleucina-6/metabolismo , Interleucina-8/metabolismo , Miócitos de Músculo Liso/imunologia , Miócitos de Músculo Liso/patologia , Ligante OX40/biossíntese , Ligante OX40/genética , Sistema Respiratório/patologia , Linfócitos T/imunologia , Linfócitos T/patologia
2.
Int Arch Allergy Immunol ; 145(2): 163-74, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-17851256

RESUMO

BACKGROUND: Viral infection causes asthma exacerbations and airway hyperreactivity. Toll-like receptor 3 (TLR3) recognizes double-stranded RNA (dsRNA) of viral or synthetic origin in a fashion different from protein kinase R (PKR). The aim of this study was to examine the expression and function of TLR3 in human airway smooth muscle (ASM) cells. METHODS: Expression of TLR3 and muscarinic receptor (MR), histamine receptor (HR), and cysteinyl leukotriene receptor (CysLTR) subtypes was analyzed by quantitative real-time PCR, flow cytometry, or Western blotting. It was assessed whether ASM cells respond to polyinosinic-polycytidylic acid (poly I:C), a synthetic analog of dsRNA, with alterations in M2R, M3R, H1R, and CysLT1R expression. The function of these subtypes was evaluated by cholinergic regulation of forskolin-stimulated cyclic AMP accumulation or by mobilization of intracellular calcium upon stimulation. RESULTS: ASM cells expressed TLR3 and PKR, and intracellular TLR3 expression was demonstrated. Poly I:C caused decreased M2R and increased M3R expression, without affecting H1R and CysLT1R expression. Poly I:C-treated cells showed decreased cholinergic inhibition of forskolin-stimulated cyclic AMP accumulation and enhanced calcium flux in response to acetylcholine, but not to histamine and LTD4. These modulating effects of poly I:C were reversed by chloroquine, but not by 2-aminopurine. CONCLUSIONS: The data indicate that poly I:C internalized by ASM cells differentially regulates M2R and M3R expression and function by interacting with TLR3 rather than with PKR, suggesting that these changes may contribute to airway hyperreactivity.


Assuntos
Hiper-Reatividade Brônquica/fisiopatologia , Miócitos de Músculo Liso/efeitos dos fármacos , Poli I-C/farmacologia , Receptor Muscarínico M2/biossíntese , Receptor Muscarínico M3/biossíntese , Receptor 3 Toll-Like/fisiologia , 2-Aminopurina/farmacologia , Sinalização do Cálcio/efeitos dos fármacos , Células Cultivadas/efeitos dos fármacos , Células Cultivadas/metabolismo , Cloroquina/farmacologia , Colforsina/farmacologia , AMP Cíclico/fisiologia , Regulação da Expressão Gênica/efeitos dos fármacos , Histamina/farmacologia , Humanos , Leucotrieno D4/farmacologia , Proteínas de Membrana/biossíntese , Proteínas de Membrana/genética , Antagonistas Muscarínicos/farmacologia , Miócitos de Músculo Liso/metabolismo , Receptor Muscarínico M2/antagonistas & inibidores , Receptor Muscarínico M2/genética , Receptor Muscarínico M3/antagonistas & inibidores , Receptor Muscarínico M3/genética , Receptores Histamínicos H1/biossíntese , Receptores Histamínicos H1/genética , Receptores de Leucotrienos/biossíntese , Receptores de Leucotrienos/genética , Transdução de Sinais/efeitos dos fármacos , eIF-2 Quinase/fisiologia
3.
Chest ; 131(2): 592-4, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17296667

RESUMO

Churg-Strauss syndrome (CSS) is an uncommon systemic vasculitis with an increase in the number of eosinophils in the peripheral blood and tissues. Its pathogenesis is unknown, and there is no evidence that genetic factors influence susceptibility to this disease. We present a case of familial CSS in two sisters with atopic-type bronchial asthma and negative perinuclear anti-neutrophil cytoplasmic antibody results. We investigated the human leukocyte antigen typing of the sisters and their six living siblings but found no evidence for heritability of CSS. To our knowledge, this is the first report of familial CSS.


Assuntos
Síndrome de Churg-Strauss/genética , Idoso , Feminino , Teste de Histocompatibilidade , Humanos , Pessoa de Meia-Idade , Irmãos
5.
Int Immunol ; 17(6): 797-805, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15899923

RESUMO

It is widely known that IL-4 and IL-13 act on various kinds of cells, including B cells, resulting in enhancement of proliferation, class switching to IgE and expression of several surface proteins. These functions are important for the recognition of the various antigens in B cells and are known to be involved in the pathogenesis of allergic diseases. However, it has not been known whether IL-4/IL-13 is involved in the metabolism of various kinds of xenobiotics including 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD), and it remains undetermined whether TCDD, an environmental pollutant, influences IgE production in B cells, exaggerating allergic reactions. We identified IL-4- or IL-13-inducible genes in a human Burkitt lymphoma cell line, DND-39, using microarray technology, in which the AHR gene was included. The AHR gene product, the aryl hydrocarbon receptor (AhR), was induced by IL-4 in both mouse and human B cells in a STAT6-dependent manner. IL-4 alone had the ability to translocate the induced AhR to the nuclei. TCDD, a ligand for AhR, rapidly degraded the induced AhR by the proteasomal pathway, although IL-4-activated AhR sustained its expression. AhR activated by IL-4 caused expression of a xenobiotic-metabolizing gene, CYP1A1, and TCDD synergistically acted on the induction of this gene by IL-4. However, the induction of AhR had no effect on IgE synthesis or CD23 expression. These results indicate that the metabolism of xenobiotics would be a novel biological function of IL-4 and IL-13 in B cells, whereas TCDD is not involved in IgE synthesis in B cells.


Assuntos
Interleucina-4/farmacologia , Receptores de Hidrocarboneto Arílico/biossíntese , Animais , Linfoma de Burkitt/enzimologia , Linfoma de Burkitt/genética , Linfoma de Burkitt/metabolismo , Linhagem Celular , Linhagem Celular Tumoral , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/metabolismo , Citocromo P-450 CYP1A1/metabolismo , Poluentes Ambientais/toxicidade , Humanos , Interleucina-13/farmacologia , Linfoma de Células B/enzimologia , Linfoma de Células B/genética , Linfoma de Células B/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Plasmídeos , Dibenzodioxinas Policloradas/toxicidade , Receptores de Hidrocarboneto Arílico/imunologia , Transfecção
6.
Cell Immunol ; 227(2): 121-8, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15135294

RESUMO

We examined the expression of recombination-activating genes (RAG-1 and RAG-2) and activation-induced cytidine deaminase (AID) by mature human blood B cells stimulated with anti-CD40 in the presence of IL-4 or IL-13. IL-4 was an effective cofactor for RAG-1 and RAG-2 expression, whereas IL-13 was not. In addition, IL-4-dependent RAG expression combined with AID and IgE expression allowed predominant expression of newly rearranged lambda light chains on IgE+ cells generated from kappa+ cells. Although the magnitudes of IL-4- and IL-13-dependent AID and IgE expression were related to expression levels of binding subunits of the IL-4 and IL-13 receptors, IL-13 was ineffective for light chain replacement in the induced IgE+ cells due to the failure in RAG expression. Our studies using mature blood B cells indicate that IL-4-responsive cells, unlike IL-13-responsive cells, undergo lambda gene rearrangement leading to replacement in parallel with RAG expression and suggest that this replacement may contribute to the regulation of affinity maturation of IgE antibodies.


Assuntos
Linfócitos B/efeitos dos fármacos , Citidina Desaminase/genética , Proteínas de Ligação a DNA/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Genes RAG-1 , Interleucina-13/farmacologia , Interleucina-4/farmacologia , Linfócitos B/metabolismo , Antígenos CD40/fisiologia , Células Cultivadas , Proteínas de Ligação a DNA/análise , Imunofluorescência , Humanos , Imunoglobulina E/genética , Imunofenotipagem , Proteínas Nucleares
7.
J Invest Dermatol ; 122(1): 20-8, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14962085

RESUMO

Keratinocytes produce many cytochemokines that are involved in the pathogenesis of skin disorders. In particular, the CC chemokines thymus and activation-regulated chemokine (TARC)/macrophage-derived chemokine (MDC) play an important role in the infiltration of Th2 cells. This study was undertaken to examine the regulatory effects of interleukin (IL)-4, IL-13, and interferon (IFN)-gamma on TARC/MDC production in the human keratinocyte cell line HaCaT. HaCaT cells spontaneously secrete TARC and MDC. The production of TARC/MDC was downregulated by IL-4/IL-13, whereas it was upregulated by IFN-gamma. To explore these regulatory mechanisms, we investigated the capacity of cytokines to regulate expression of several adhesion molecules that may affect TARC/MDC production. Of the adhesion molecules examined, the constitutive surface expression of E-cadherin was downregulated by IL-4/IL-13, but was upregulated by IFN-gamma. Moreover, disruption of the homophilic adherence of E-cadherin by anti-E-cadherin antibody or calcium chelation abolished the production of TARC/MDC. We further examined the distribution of the adherens junction complex composed of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin. IL-4/IL-13 decreased the levels of membrane staining for adherens junction proteins, whereas IFN-gamma increased membrane staining. Taken together, these results suggest that IL-4/IL-13 and IFN-gamma induce alternations in the distribution of adherens junctions in a different fashion and thereby contribute to the reciprocal regulation of TARC/MDC production.


Assuntos
Caderinas/metabolismo , Quimiocinas CC/metabolismo , Citocinas/farmacologia , Queratinócitos/metabolismo , Junções Aderentes/efeitos dos fármacos , Junções Aderentes/metabolismo , Antineoplásicos/farmacologia , Adesão Celular/fisiologia , Linhagem Celular , Quimiocina CCL17 , Quimiocina CCL22 , Quimiocinas CC/genética , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/imunologia , Expressão Gênica/efeitos dos fármacos , Expressão Gênica/imunologia , Humanos , Interferon gama/farmacologia , Interleucina-13/farmacologia , Interleucina-4/farmacologia , Queratinócitos/imunologia , RNA Mensageiro/análise , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/imunologia
8.
J Dermatol Sci ; 30(1): 29-36, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12354417

RESUMO

The CC chemokine thymus- and activation-regulated chemokine (TARC/CCL17) acts on CC chemokine receptor 4 (CCR4), which is known to be selectively expressed in Th2 cells. In order to compare the regulatory profiles of TARC production by tumor necrosis factor-alpha (TNF-alpha), IFN-gamma, interleukin-4 (IL-4) and IL-13 in keratinocytes and fibroblasts, HaCaT cells, a human keratinocyte cell line, and NG1RGB cells, a human skin fibroblast cell line, were used. The expression of TARC protein was measured using enzyme-linked immunosorbent assay (ELISA), and the mRNA level was detected by reverse transcriptase polymerase chain reaction (RT-PCR). The spontaneous expression of TARC protein and mRNA levels were augmented by TNF-alpha and IFN-gamma and were inhibited by IL-4 and IL-13 in the keratinocytes. The fibroblasts expressed the TARC protein and mRNA only in the presence of IL-4+TNF-alpha or IL-13+TNF-alpha stimulation. IFN-gamma further enhanced the IL-4+TNF-alpha or IL-13+TNF-alpha-induced TARC production in the fibroblasts. Thus, TNF-alpha and IFN-gamma -induced TARC production was differentially regulated by IL-4 and IL-13 in human keratinocytes and fibroblasts.


Assuntos
Quimiocinas CC/genética , Quimiocinas/genética , Fibroblastos/imunologia , Interferon gama/farmacologia , Interleucina-13/farmacologia , Interleucina-4/farmacologia , Queratinócitos/imunologia , Timo/imunologia , Fator de Necrose Tumoral alfa/farmacologia , Sequência de Bases , Linhagem Celular , Quimiocina CCL17 , Primers do DNA , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/imunologia , Humanos , Cinética , Ativação Linfocitária , RNA Mensageiro/genética , Pele/citologia , Pele/imunologia , Células Th2/imunologia
9.
Arch Biochem Biophys ; 405(2): 199-204, 2002 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-12220533

RESUMO

Induction of germline C epsilon transcription in B cells by IL-4, which is a critical initiating step for IgE class switching, is enhanced by CD40 engagement. Although signaling by CD40 is initiated by the binding of tumor necrosis factor receptor-associated factor (TRAF) family members to its cytoplasmic domain, whether those TRAF family proteins mediate enhancement of germline Cepsilon transcription is not evident. We report here that CD40-induced TRAF3-dependent activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase 1 (MEK1) is involved in the upregulation of IL-4-driven germline C epsilon transcription in a human Burkitt's lymphoma B cell line, DG75. Among the six known TRAF proteins, TRAF2, 3, 5, and 6 associated with CD40 in an unstimulated state, and the levels of these four proteins were unaffected by anti-CD40 stimulation. Antisense oligodeoxynucleotide (ODN) for TRAF3 inhibited CD40-induced activation of MEK1-ERK pathway by decreasing expression of TRAF3 protein, but antisense ODNs for TRAF2, 5, and 6 were ineffective. Furthermore, CD40-mediated enhancement of IL-4-driven germline C epsilon transcription was inhibited by antisense ODN for TRAF3 and by a MEK1 inhibitor, PD98059. These results suggest that in DG75 cells, TRAF3-induced MEK1 activation may be involved in CD40-mediated upregulation of IL-4-driven germline C epsilon transcription.


Assuntos
Linfoma de Burkitt/fisiopatologia , Antígenos CD40/metabolismo , Cadeias épsilon de Imunoglobulina/genética , Interleucina-4/metabolismo , Proteínas/metabolismo , Transcrição Gênica , Antígenos CD40/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Flavonoides/farmacologia , Células Germinativas , Humanos , Cadeias épsilon de Imunoglobulina/efeitos dos fármacos , Cadeias épsilon de Imunoglobulina/metabolismo , Interleucina-4/farmacologia , MAP Quinase Quinase 1 , Quinases de Proteína Quinase Ativadas por Mitógeno/antagonistas & inibidores , Quinases de Proteína Quinase Ativadas por Mitógeno/metabolismo , Oligonucleotídeos Antissenso/farmacologia , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas/efeitos dos fármacos , Proteínas/genética , Fator 2 Associado a Receptor de TNF , Fator 3 Associado a Receptor de TNF , Fator 5 Associado a Receptor de TNF , Fator 6 Associado a Receptor de TNF , Células Tumorais Cultivadas , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...